NP 016
/ Abionyx Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 24, 2011
Therapeutic potential of panduratin A, LKB1-dependent AMP-activated protein kinase stimulator, with activation of PPARα/δ for the treatment of obesity
(Diabetes Obes Metab)
- PAN A, an LKB1-dependent AMPK stimulator, activated PPARα/δ & attenuated HFD-induced obesity & dysregulation of lipid metabolism; Study suggests that PAN A is a potent AMPK activator & show a novel molecular mechanism for the treatment of metabolic disorders
1 to 1
Of
1
Go to page
1